Transmedics Group, Inc. balance sheet
At the end of fiscal 2025, Transmedics Group, Inc. had total assets of $1.07bn, total liabilities of $595m and shareholders' equity of $473m. It held $489m in cash against $463m of debt: net cash of $26.1m.
Balance sheet
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20 | 21 | 25 | 26 | 201 | 395 | 337 | 489 | 491 |
| Receivables | 3 | 7 | 7 | 6 | 28 | 64 | 98 | 84 | 104 |
| Inventory | 9 | 11 | 12 | 15 | 21 | 44 | 47 | 49 | 54 |
| Total current assets | 35 | 100 | 147 | 119 | 252 | 511 | 497 | 638 | 651 |
| Goodwill | — | — | — | — | — | 12 | 12 | 12 | 12 |
| Total assets | 42 | 105 | 152 | 135 | 277 | 706 | 804 | 1,068 | 1,464 |
| Accounts payable | 5 | 7 | 1 | 7 | 3 | 13 | 10 | 10 | 13 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 3 |
| Total current liabilities | 13 | 16 | 12 | 23 | 24 | 55 | 60 | 89 | 98 |
| Short-term debt | — | — | — | — | — | — | — | 10 | 20 |
| Long-term debt | 34 | 34 | 35 | 35 | 59 | — | — | — | — |
| Total debt | 35 | 34 | 35 | 35 | 60 | 447 | 450 | 463 | 474 |
| Total liabilities | 48 | 51 | 48 | 67 | 90 | 569 | 575 | 595 | 946 |
| Shareholders' equity | −192 | 55 | 104 | 68 | 187 | 137 | 229 | 473 | 518 |
| Non-controlling interests and other (assets − liabilities − equity) | 187 | — | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | 15 | 14 | 10 | 10 | −141 | 52 | 113 | −26 | −17 |
| Shares outstanding | 14m | — | 27m | 28m | 32m | 33m | 34m | 34m | 35m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 90 | 98 | 142 | 105 | 81 | 84 | 91 | 104 |
| Inventory | 52 | 47 | 43 | 39 | 45 | 49 | 50 | 54 |
| Total current assets | 492 | 497 | 506 | 558 | 613 | 638 | 619 | 651 |
| Goodwill | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Total assets | 786 | 804 | 838 | 891 | 946 | 1,068 | 1,435 | 1,464 |
| Accounts payable | 13 | 10 | 11 | 10 | 12 | 10 | 11 | 13 |
| Deferred revenue (current) | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Total current liabilities | 60 | 60 | 56 | 57 | 80 | 89 | 92 | 98 |
| Short-term debt | — | — | — | — | 5 | 10 | 15 | 20 |
| Total debt | — | — | — | — | 5 | 10 | 15 | 20 |
| Total liabilities | 576 | 575 | 571 | 572 | 591 | 595 | 941 | 946 |
| Shareholders' equity | 210 | 229 | 266 | 318 | 355 | 473 | 494 | 518 |
| Shares outstanding | 34m | 34m | 34m | 34m | 34m | 34m | 35m | 35m |
Compare with peers
- Glaukos Corp balance sheet
- Novocure Ltd balance sheet
- Bioventus Inc. balance sheet
- Atricure, Inc. balance sheet
- Myriad Genetics Inc balance sheet
Head to head: GKOS vs TMDXNVCR vs TMDXBVS vs TMDXATRC vs TMDX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies